EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Are genotypes of Trypanosoma cruzi involved in the challenge of chagasic cardiomyopathy?


Parasitology Research 84(2): 147-152
Are genotypes of Trypanosoma cruzi involved in the challenge of chagasic cardiomyopathy?
Myocardial damage in Chagas' disease differs, depending on the particular Trypanosoma cruzi stock. It is reasonable to expect that the extent of phylogenetic divergence between lineages will have an impact on the biological properties of the parasite. The aim of the present work was to evaluate this impact on the cardiac damage produced by this protozoan. Heart histopathologic lesions were studied in mice infected with 15 cloned stocks of T. cruzi of various origins pertaining to 3 major clones or genotypes (19, 20, and 39) that share 3 different profiles for a given set of genetic markers. Sets of mice were infected intraperitoneally with 10(6) blood trypomastigotes of each of the T. cruzi clones. The macroscopy study showed a cardiac index (CI) higher than 0.6 (cardiomegaly) in 5 of the 15 stocks studied (33.33%). Inflammatory infiltrates appeared in stocks pertaining to the three genotypes studied without relation to the genetic pattern. Pseudocysts were present at higher levels (83%) in stocks pertaining to genotype 39. A lower rate could be seen in stocks pertaining to genotype 19 (50%). Only one stock pertaining to genotype 20 presented myocardial parasites (20%). Hearts were also studied for lesions in the different cardiac chambers. Inflammatory foci as well as pseudocysts appeared mainly in ventricles, with the left ventricle sharing the highest percentage of pathologic findings. In summary, in spite of the similar inflammatory pattern demonstrated for all stocks studied, the parasite's presence seemed to be related to the genotype of reference, but no relation could be demonstrated with the genetic distances.


Accession: 003046135

PMID: 9493216

DOI: 10.1007/s004360050373



Related references

Chagas cardiomyopathy manifestations and Trypanosoma cruzi genotypes circulating in chronic Chagasic patients. Plos Neglected Tropical Diseases 4(11): E899-E899, 2011

Persistence of Trypanosoma cruzi in Experimental Chagasic Cardiomyopathy. 2012

Identification of Trypanosoma cruzi genotypes circulating in Chilean chagasic patients. Experimental Parasitology 97(4): 226-233, 2001

Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli. Acta Tropica 56(4): 265-287, 1994

Amplification of a trypanosoma cruzi dna sequence from inflammatory lesions of human chagasic cardiomyopathy. Clinical Research 40(2): 330A, 1992

Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. American Journal of Tropical Medicine and Hygiene 48(3): 348-357, 1993

A Trypanosoma cruzi DNA sequence amplified from inflammatory lesions in human chagasic cardiomyopathy. Transactions of the Association of American Physicians 105: 182-189, 1992

Contribution of the Trypanosoma cruzi Genome Project to the understanding of the pathogenesis of chronic chagasic cardiomyopathy. Medicina Buenos Aires 59(Supplement II): 18-24, 1999

Analysis of association of FOXO3 gene with Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy. Hla 87(6): 449-452, 2016

Trypanosoma cruzi isoenzyme variability in Ecuador: first observation of zymodeme III genotypes in chronic chagasic patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 96(4): 378-382, 2002